Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(3,5-bis(trimethylsilyl)benzamido)benzoic Acid
2. Am 555s
3. Am-555s
4. Am555s
5. Tac 101
6. Tac-101
1. 125973-56-0
2. Tac-101
3. Am 555s
4. Amsilarotene [inn]
5. Am555s,tac-101
6. 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic Acid
7. Amsilarotene; Tac 101
8. Q1418f39mh
9. 4-[3,5-bis(trimethylsilyl) Benzamido] Benzoic Acid
10. Benzoic Acid, 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]-
11. Am-555s
12. Tac 101
13. 4-(3,5-bis(trimethylsilyl)benzamido)benzoic Acid
14. Benzoic Acid, 4-((3,5-bis(trimethylsilyl)benzoyl)amino)-
15. Unii-q1418f39mh
16. Ccris 9419
17. 4-(3,5-bis(trimethylsilyl)benzamido) Benzoic Acid
18. Amsilarotene [who-dd]
19. Chembl32994
20. Schembl1133175
21. Dtxsid90155013
22. Ex-a128
23. Bcp06502
24. Akos032947226
25. Zinc169746726
26. Ac-36797
27. Da-13333
28. Hy-14653
29. Cs-0003504
30. Ft-0769431
31. A13122
32. Q27286879
33. 5-(4-methylphenyl)furan-2-carboxylicacidmethylester
| Molecular Weight | 385.6 g/mol |
|---|---|
| Molecular Formula | C20H27NO3Si2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 385.15294679 g/mol |
| Monoisotopic Mass | 385.15294679 g/mol |
| Topological Polar Surface Area | 66.4 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 494 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Tac 101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tac 101, including repackagers and relabelers. The FDA regulates Tac 101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tac 101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tac 101 supplier is an individual or a company that provides Tac 101 active pharmaceutical ingredient (API) or Tac 101 finished formulations upon request. The Tac 101 suppliers may include Tac 101 API manufacturers, exporters, distributors and traders.
click here to find a list of Tac 101 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tac 101 DMF (Drug Master File) is a document detailing the whole manufacturing process of Tac 101 active pharmaceutical ingredient (API) in detail. Different forms of Tac 101 DMFs exist exist since differing nations have different regulations, such as Tac 101 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tac 101 DMF submitted to regulatory agencies in the US is known as a USDMF. Tac 101 USDMF includes data on Tac 101's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tac 101 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tac 101 suppliers with USDMF on PharmaCompass.
Tac 101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tac 101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tac 101 GMP manufacturer or Tac 101 GMP API supplier for your needs.
A Tac 101 CoA (Certificate of Analysis) is a formal document that attests to Tac 101's compliance with Tac 101 specifications and serves as a tool for batch-level quality control.
Tac 101 CoA mostly includes findings from lab analyses of a specific batch. For each Tac 101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tac 101 may be tested according to a variety of international standards, such as European Pharmacopoeia (Tac 101 EP), Tac 101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tac 101 USP).
LOOKING FOR A SUPPLIER?
